Annual report pursuant to Section 13 and 15(d)

7. Common Stock and Equity Payable (Details)

v3.19.1
7. Common Stock and Equity Payable (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 06, 2018
shares
Feb. 07, 2018
USD ($)
employee
$ / shares
shares
Oct. 19, 2018
$ / shares
shares
Sep. 30, 2018
USD ($)
shares
Aug. 29, 2018
USD ($)
$ / shares
shares
Jun. 30, 2018
USD ($)
$ / shares
shares
Feb. 23, 2018
shares
Dec. 21, 2017
USD ($)
employee
$ / shares
shares
Nov. 30, 2017
item
shares
Aug. 30, 2017
USD ($)
employee
$ / shares
shares
Aug. 22, 2017
USD ($)
employee
$ / shares
shares
Jul. 17, 2017
employee
shares
Jun. 27, 2017
USD ($)
employee
$ / shares
shares
Mar. 31, 2018
employee
shares
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                                
Stock-based compensation expense                             $ 260,000  
Shares issued | shares 8,426 12,500 84,679   24,792 1,047,583 1,808 47,917 220,327 37,500 4,688 263,731 61,980 2,018,125    
Shares Issued, Price Per Share | $ / shares   $ 0.78 $ 1.20   $ 0.48     $ 0.48   $ 0.75 $ 0.41   $ 0.48      
Proceeds from issuance of common stock, gross   $ 9,595     $ 11,875     $ 23,000   $ 28,125 $ 1,922   $ 29,750      
Common Stock For Cashless Transaction For Warrant Exercise | shares 25,000           25,000                  
Common stock issued for warrant exercise | shares     101,615                     2,018,125    
Offering Price | $ / shares           $ 1.00                    
Sale of common stock | shares       5,775,000                        
Proceeds from sale of common stock       $ 5,775,000                        
Loss on conversion           $ 41,902                    
Number of employees that exercised vested stock options | employee   1           1   1 1   1 1    
Number of board members, issued stock from restricted stock agreement | employee                       4        
Number of former board members, shares issued from restricted stock agreement | item                 2              
Equity payable                             $ 100,862 $ 100,862
Principal                                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                                
Face amount           1,000,000                    
Accrued interest                                
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                                
Face amount           $ 47,583